Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

NCT05776134 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Mantle Cell Lymphoma
Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: Brexucabtagene Autoleucel

Sponsor

Kite, A Gilead Company